- Cyclic
- Calcitonin gene-related
- Caspase related
- Amyloid
- Adrenomedullin
- Amylin
- Tau
- Cosmetic
- Anti-microbial
- G-protein-coupled receptors (GPCR)
- Others
Catalog Peptides Market size was valued at USD 235.59 million in 2022 and is poised to grow at a CAGR of 8% from 2023-2029. The catalog peptide market is witnessing growth due to technological advances that aid in the cost-effective manufacture of peptides. Previously, peptides were synthesized from natural sources such as porcine-derived adrenocorticotropic hormone (ACTH) or bovine pituitary, and bovine or canine pancreatic insulin. Growing research activities to address unmet medical needs in various therapeutic areas, raising the burden of chronic diseases, and increasing investment and funding for protein-based research are among the key factors driving the market growth. Nevertheless, the absence of a coherent collection of regulations restrains business development.
Catalog Peptides Market key Developments:
- In February 2017 to expand its product portfolio by incorporating proteins, antibodies, and enzyme-linked immunosorbent assays (ELISA) into GenWay's product portfolio and to become a key provider of proteomic solutions on the market.
- In January 2017, the PolyPeptide Group announced the completion of its acquisition of the peptides business and operations of Lonza in Braine-Alleud, Belgium.
Catalog Peptides Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
8%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Catalog Peptides Market Dynamics
Recently there has been an increase in the number of research activities undertaken, especially in the areas of drug development, antibody production, disease research, and therapy. The increased emphasis on these areas allows for the revealing of novel techniques, many of which involve peptide use and synthesis. The increase in the number of research activities can be attributed to the rising demand for catalogue peptides which further increases the market share of the global catalogue peptides.
North-America Got Significant Share
Catalog Peptides Market Regional Analysis
North America is predicted to have the largest share of the Nucleic Acid Amplification Testing market by 2027, and it is expected to grow at a rapid pace in the following years. Because of improved healthcare infrastructure and the increased prevalence of infectious diseases, the United States is predicted to be the largest nucleic acid amplification testing market. NAAT was deployed in Canada by the Canadian Blood Services, and it is helping to ensure a safer blood supply by detecting tiny quantities of viral genetic material.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The catalog peptides market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Catalog Peptides Market Segmentation
By Technique
By Application
- Commercial
- Antibody production
- Drug discovery
- Enzyme profiling
- Others
- Academic Research
- Disease research
- Cancer and apoptosis
- Cardiovascular
- Diabetes
- Neuroscience
- Infectious diseases
- Anti-inflammatory
- Blood disorders
- Others
- Biomarker discovery
- Others
- Disease research
- Therapeutics
By Geography
- Pharmaceutical and Biotechnology Companies
- Contract manufacturing organizations (CMOs) and Contract research organizations (CROs)
- Academic and Research Institutes
By Geography
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Frequently Asked Questions
The global catalog peptides market size was valued at usd 235.59 million in 2022
The catalog peptides market key players are PolyPeptide Group, CSBio, GL Biochem Ltd., CPC Scientific Inc., Peptides International Ltd., Applied Biological Materials Inc.
North America is dominating the catalog peptides market
| 1. Executive Summary |
| 2. Global Catalog Peptide Market Introduction |
| 2.1. Global Catalog Peptide Market Taxonomy |
| 2.2. Global Catalog Peptide Market Definitions |
| 2.2.1. By Peptide Type |
| 2.2.2. By Disease Type |
| 2.2.3. By Application |
| 2.2.4. By End User |
| 2.2.5. By Region |
| 3. Global Catalog Peptide Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Catalog Peptide Market Dynamic Factors - Impact Analysis |
| 3.6. Global Catalog Peptide Market Competition Landscape |
| 4. Global Catalog Peptide Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Catalog Peptide Market, By Peptide Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1. Adrenomedullin |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. G-Protein-Coupled Receptors (GPCR) |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Amyloid |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Caspase Related |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Calcitonin Gene-Related |
| 5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Cyclic |
| 5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Amylin |
| 5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Tau |
| 5.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 5.9. Others |
| 5.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.9.3. Market Opportunity Analysis |
| 6. Global Catalog Peptide Market, By Disease Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1. Cancer and Apoptosis |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Cardiovascular |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Diabetes |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Neuroscience |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Infectious Diseases |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Anti-inflammatory |
| 6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Blood Disorders |
| 6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 6.8. Others |
| 6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.8.3. Market Opportunity Analysis |
| 7. Global Catalog Peptide Market, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1. Antibody Production |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Drug Discovery |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Enzyme Profiling |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Biomarker Discovery |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global Catalog Peptide Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1. Pharmaceutical and Biotechnology Companies |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. CROs and CMOs |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Academic and Research Institutes |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Catalog Peptide Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Catalog Peptide Market - Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Region, 2023 - 2029 |
| 10. North America Catalog Peptide Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 10.1. Peptide Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Adrenomedullin |
| 10.1.2. G-Protein-Coupled Receptors (GPCR) |
| 10.1.3. Amyloid |
| 10.1.4. Caspase Related |
| 10.1.5. Calcitonin Gene-Related |
| 10.1.6. Cyclic |
| 10.1.7. Amylin |
| 10.1.8. Tau |
| 10.1.9. Others |
| 10.2. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Cancer and Apoptosis |
| 10.2.2. Cardiovascular |
| 10.2.3. Diabetes |
| 10.2.4. Neuroscience |
| 10.2.5. Infectious Diseases |
| 10.2.6. Anti-inflammatory |
| 10.2.7. Blood Disorders |
| 10.2.8. Others |
| 10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Antibody Production |
| 10.3.2. Drug Discovery |
| 10.3.3. Enzyme Profiling |
| 10.3.4. Biomarker Discovery |
| 10.3.5. Others |
| 10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Pharmaceutical and Biotechnology Companies |
| 10.4.2. CROs and CMOs |
| 10.4.3. Academic and Research Institutes |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America Catalog Peptide Market - Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Country, 2023 - 2029 |
| 10.7. North America Catalog Peptide Market Dynamics Trends |
| 11. Europe Catalog Peptide Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 11.1. Peptide Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Adrenomedullin |
| 11.1.2. G-Protein-Coupled Receptors (GPCR) |
| 11.1.3. Amyloid |
| 11.1.4. Caspase Related |
| 11.1.5. Calcitonin Gene-Related |
| 11.1.6. Cyclic |
| 11.1.7. Amylin |
| 11.1.8. Tau |
| 11.1.9. Others |
| 11.2. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Cancer and Apoptosis |
| 11.2.2. Cardiovascular |
| 11.2.3. Diabetes |
| 11.2.4. Neuroscience |
| 11.2.5. Infectious Diseases |
| 11.2.6. Anti-inflammatory |
| 11.2.7. Blood Disorders |
| 11.2.8. Others |
| 11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Antibody Production |
| 11.3.2. Drug Discovery |
| 11.3.3. Enzyme Profiling |
| 11.3.4. Biomarker Discovery |
| 11.3.5. Others |
| 11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Pharmaceutical and Biotechnology Companies |
| 11.4.2. CROs and CMOs |
| 11.4.3. Academic and Research Institutes |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Rest of Europe |
| 11.6. Europe Catalog Peptide Market - Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Country, 2023 - 2029 |
| 11.7. Europe Catalog Peptide Market Dynamics Trends |
| 12. Asia-Pacific Catalog Peptide Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 12.1. Peptide Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Adrenomedullin |
| 12.1.2. G-Protein-Coupled Receptors (GPCR) |
| 12.1.3. Amyloid |
| 12.1.4. Caspase Related |
| 12.1.5. Calcitonin Gene-Related |
| 12.1.6. Cyclic |
| 12.1.7. Amylin |
| 12.1.8. Tau |
| 12.1.9. Others |
| 12.2. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Cancer and Apoptosis |
| 12.2.2. Cardiovascular |
| 12.2.3. Diabetes |
| 12.2.4. Neuroscience |
| 12.2.5. Infectious Diseases |
| 12.2.6. Anti-inflammatory |
| 12.2.7. Blood Disorders |
| 12.2.8. Others |
| 12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Antibody Production |
| 12.3.2. Drug Discovery |
| 12.3.3. Enzyme Profiling |
| 12.3.4. Biomarker Discovery |
| 12.3.5. Others |
| 12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Pharmaceutical and Biotechnology Companies |
| 12.4.2. CROs and CMOs |
| 12.4.3. Academic and Research Institutes |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. China |
| 12.5.2. India |
| 12.5.3. Japan |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Catalog Peptide Market - Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Country, 2023 - 2029 |
| 12.7. Asia-Pacific Catalog Peptide Market Dynamics Trends |
| 13. Latin America Catalog Peptide Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 13.1. Peptide Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Adrenomedullin |
| 13.1.2. G-Protein-Coupled Receptors (GPCR) |
| 13.1.3. Amyloid |
| 13.1.4. Caspase Related |
| 13.1.5. Calcitonin Gene-Related |
| 13.1.6. Cyclic |
| 13.1.7. Amylin |
| 13.1.8. Tau |
| 13.1.9. Others |
| 13.2. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Cancer and Apoptosis |
| 13.2.2. Cardiovascular |
| 13.2.3. Diabetes |
| 13.2.4. Neuroscience |
| 13.2.5. Infectious Diseases |
| 13.2.6. Anti-inflammatory |
| 13.2.7. Blood Disorders |
| 13.2.8. Others |
| 13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Antibody Production |
| 13.3.2. Drug Discovery |
| 13.3.3. Enzyme Profiling |
| 13.3.4. Biomarker Discovery |
| 13.3.5. Others |
| 13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Pharmaceutical and Biotechnology Companies |
| 13.4.2. CROs and CMOs |
| 13.4.3. Academic and Research Institutes |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Rest of Latin America |
| 13.6. Latin America Catalog Peptide Market - Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Country, 2023 - 2029 |
| 13.7. Latin America Catalog Peptide Market Dynamics Trends |
| 14. Middle East and Africa Catalog Peptide Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 14.1. Peptide Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Adrenomedullin |
| 14.1.2. G-Protein-Coupled Receptors (GPCR) |
| 14.1.3. Amyloid |
| 14.1.4. Caspase Related |
| 14.1.5. Calcitonin Gene-Related |
| 14.1.6. Cyclic |
| 14.1.7. Amylin |
| 14.1.8. Tau |
| 14.1.9. Others |
| 14.2. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. Cancer and Apoptosis |
| 14.2.2. Cardiovascular |
| 14.2.3. Diabetes |
| 14.2.4. Neuroscience |
| 14.2.5. Infectious Diseases |
| 14.2.6. Anti-inflammatory |
| 14.2.7. Blood Disorders |
| 14.2.8. Others |
| 14.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Antibody Production |
| 14.3.2. Drug Discovery |
| 14.3.3. Enzyme Profiling |
| 14.3.4. Biomarker Discovery |
| 14.3.5. Others |
| 14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Pharmaceutical and Biotechnology Companies |
| 14.4.2. CROs and CMOs |
| 14.4.3. Academic and Research Institutes |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. South Africa |
| 14.5.3. Rest of MEA |
| 14.6. MEA Catalog Peptide Market - Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Country, 2023 - 2029 |
| 14.7. MEA Catalog Peptide Market Dynamics Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Bachem AG |
| 15.2.2. JPT Peptide Technologies GmbH |
| 15.2.3. AAPPTEC |
| 15.2.4. Kaneka Eurogentec S.A. |
| 15.2.5. Biopeptek Pharmaceuticals LLC |
| 15.2.6. Vivitide, LLC |
| 15.2.7. Abbiotec Inc. |
| 15.2.8. Auspep Pty Ltd. |
| 15.2.9. Peptides International Inc. |
| 15.2.10. Thermo Fisher Scientific Inc. |
| 15.2.11. GenScript Biotech Corporation |
| 15.2.12. Creative Peptides |
| 15.2.13. KareBay Biochem Inc. |
| 15.2.14. Ontores Biotechnologies Inc. |
| 15.2.15. Severn Biotech Ltd. |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
- PolyPeptide Group
- CSBio
- GL Biochem Ltd.
- CPC Scientific Inc.
- Peptides International Ltd.
- Applied Biological Materials Inc.
- Biomatik Corporation
- Bio-Synthesis Inc.
- Advanced ChemTech
- Creative Peptides